Back

Enliven Therapeutics Stock Predictions

Better Than Oil Stocks

CLICK HERE TO FIND OUT MORE

Sell

ELVN
Enliven Therapeutics

Last Price:

24.13

Seasonality Move:

-7.59%

7 Day Trial

ALL ACCESS PASS

$ 7

Zero Day Options Trade LIVE Tuesday at 2 p.m. ET!

Discover The Zero Day Loophole (BEFORE Tues at 2 p.m. ET!)

Enliven Therapeutics Stock Forecast

Over the next 52 weeks, Enliven Therapeutics has on average historically risen by 9.2% based on the past 4 years of stock performance.
Enliven Therapeutics has risen higher in 2 of those 4 years over the subsequent 52-week period, corresponding to a historical accuracy of 50%
Is Enliven Therapeutics Stock Undervalued?
The current Enliven Therapeutics [ELVN] share price is $23.79. The Score for ELVN is 29, which is 42% below its historic median score of 50, and infers higher risk than normal.
ELVN is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.

Will Enliven Therapeutics Stock Go Up Next Year?

Over the next 52 weeks, Enliven Therapeutics has on average historically risen by 9.2% based on the past 4 years of stock performance.

Enliven Therapeutics Stock Rating

Sell

Enliven Therapeutics (ELVN) is a Sell

Is Enliven Therapeutics overpriced?

Enliven Therapeutics has risen higher in 2 of those 4 years over the subsequent 52-week period, corresponding to a historical accuracy of 50%

Enliven Therapeutics Stock Price History

Is ELVN stock going to rise?

Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ELVN is experiencing slight selling pressure.

Stock Information

Stock Info

Exchange:

NASDAQ

Country:

United States

Industry:

Pharmaceuticals

Sector:

Health Care

Type:

stock

Website:

enliventherapeutics.com

52-Week Data

52-Week High:

30.03

52-Week Low:

9.80

Prediction Charts

Market Cap:

1.16B

Price in USD:

23.79

Volume:

90.88K

Beta:

0.91

Technical Analysis

SMA50:

26.73

SMA100:

24.95

SMA200:

22.55

52-Wk Change:

98.42%

Stock Predictions

Is Enliven Therapeutics stock public?
Yes, Enliven Therapeutics is a publicly traded company.
What is the Enliven Therapeutics stock quote today?
The Enliven Therapeutics stock price is 23.79 USD today.
How to buy Enliven Therapeutics stock online?
You can buy Enliven Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date	Opening	Closing	Minimum	Maximum
Nov-20	26.25	25.43	26.48	24.98
Nov-21	25.59	25.41	25.76	24.69
Nov-22	25.50	24.54	26.09	24.36
Nov-25	24.72	24.88	25.64	24.64
Nov-26	24.88	24.35	25.07	24.10
Nov-27	24.45	25.41	25.67	24.45
Nov-29	25.26	24.38	25.63	24.30
Dec-2	24.49	24.43	25.28	24.36
Dec-3	24.07	23.61	25.79	22.59
Dec-4	23.61	23.71	23.98	23.24
Dec-5	23.71	23.25	24.15	23.04
Dec-6	23.62	25.42	25.96	23.59
Dec-9	25.67	24.42	25.67	23.95
Dec-10	24.34	23.79	24.45	23.51

Enliven Therapeutics Earnings

Enliven Therapeutics Earnings Report: Per Share Enliven Therapeutics Earnings Q1 Q2 Q3 and Q4 last year and next year.

Enliven Therapeutics Forecast Revenue Growth

Enliven Therapeutics Stock Analysis: Historical quarterly revenues per share for Enliven Therapeutics and historical quarterly revenue growth:

Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.18 per share, and a decrease next year of $0.48 per share.

* Enliven Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.